A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study).

Choy H, Devore RF, Hande KR, Porter LL, Rosenblatt P, Yunus F, Schlabach L, Smith C, Shyr Y, Johnson DH
Int J Radiat Oncol Biol Phys. 2000 47 (4): 931-7

PMID: 10863062 · DOI:10.1016/s0360-3016(00)00420-x

MeSH Terms (22)

Adenocarcinoma Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols Carboplatin Carcinoma, Large Cell Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Disease Progression Dose Fractionation, Radiation Drug Administration Schedule Female Humans Lung Neoplasms Male Middle Aged Neoplasm Staging Paclitaxel Prospective Studies Radiation-Sensitizing Agents Survival Rate

Connections (1)

This publication is referenced by other Labnodes entities: